Detalhe da pesquisa
1.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Blood
; 142(23): 1960-1971, 2023 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37647654
2.
Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia.
Br J Haematol
; 204(5): 1732-1739, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38198799
3.
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.
Blood
; 133(15): 1630-1643, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803991
4.
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era.
Blood
; 129(13): 1763-1767, 2017 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28082441
5.
Optimal approach for high-risk acute promyelocytic leukemia.
Curr Opin Hematol
; 21(2): 102-13, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24378704
6.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood
; 120(8): 1570-80; quiz 1752, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22715121
7.
Role of arsenic trioxide in acute promyelocytic leukemia.
Curr Treat Options Oncol
; 14(2): 170-84, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23322117
8.
Applying molecular measurable residual disease testing in acute myeloid leukaemia.
Pathology
; 55(1): 1-7, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503638
9.
Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1.
Haematologica
; 97(1): 64-72, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993678
10.
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia.
Haematologica
; 97(2): 227-34, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21993673
11.
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statement.
Pathology
; 54(4): 389-398, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461716
12.
Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia.
Blood Adv
; 6(11): 3433-3439, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349669
13.
Laboratory quality assessment of candidate gene panel testing for acute myeloid leukaemia: a joint ALLG / RCPAQAP initiative.
Pathology
; 53(4): 487-492, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33272691
14.
Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.
Australas J Dermatol
; 50(1): 56-9, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19178495
15.
Curative strategies in APL.
Semin Hematol
; 56(2): 131-138, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30926089
16.
CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation.
Mol Oncol
; 13(10): 2107-2120, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31338922
17.
A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission.
Oncoimmunology
; 7(4): e1419114, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632738
18.
Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.
Blood Adv
; 7(11): 2580-2585, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075018
19.
Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives.
Onco Targets Ther
; 10: 1585-1601, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28352191
20.
Molecular biology of lymphoma in the microarray era.
Pathology
; 37(6): 508-22, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16373230